Plain-English translation of NCT06463366 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing whether advanced MRI scanning techniques can accurately detect and measure liver damage—including scarring, inflammation, and fat buildup—in people with chronic liver disease. Instead of relying on painful liver biopsies, these new MRI methods aim to provide a safe, non-invasive way to track how well your liver is responding to treatment over time.
Many patients with chronic liver disease currently need liver biopsies to assess damage, but biopsies are painful, expensive, and can only sample a tiny piece of your liver. This trial exists to validate whether advanced MRI imaging can give doctors a complete, accurate picture of liver health without the risks and limitations of a biopsy.
You likely qualify if…
You likely don't qualify if…
You would visit the hospital for advanced MRI scans of your liver, with follow-up visits every 6 months to track changes in your liver over time. The MRI scans are painless and non-invasive—you simply lie still in the MRI machine while detailed images are taken. Researchers will use these images along with your treatment information to build and test a new method for predicting how well your liver is responding to therapy.
AI-generated summary from trial data · Jul 2, 2026 · Not medical advice
China
Sponsor
Shengjing Hospital
Enrollment target
~100 participants
Started
June 2022
Primary completion
February 2023
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 75 Years
Last updated on clinicaltrials.gov in February 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Yu Shi
Shengjing Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.